When: Wednesday, October 15, 2003
9:00 a.m. - 3:00 p.m.
Where: Molecular Biology Building Atrium
Why: Discover opportunities in biotechnology!

Protein Design Labs, Inc.

Protein Design Labs, Inc. is a leader in the development of humanized monoclonal antibodies to treat various disease conditions. We currently have antibodies in clinical development for autoimmune and inflammatory conditions, asthma and cancer. Our goal is to become a profitable company that manufactures and markets innovative products to meet important medical needs.

We hold fundamental patents in the U.S., Europe and Japan that cover our antibody humanization technology. This technology is also used by numerous other pharmaceutical and biotechnology companies, many of which have licensed our patents, and have agreed to pay royalties to us on any sales of licensed products. We receive royalties on sales of all four of the currently marketed humanized antibodies.